Citation: Pj. O'Dwyer et al., Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study, J CL ONCOL, 19(9), 2001, pp. 2413-2421
Authors:
Laport, GG
Valone, FH
Zimmerman, TM
Grinblatt, DL
Van Vlasselaer, P
Still, BJ
Williams, SF
Citation: Gg. Laport et al., Transplantation with low-density autologous PBSC prepared with BDS60 for women with stage II, III and IV breast cancer, CYTOTHERAPY, 2(3), 2000, pp. 179-185
Authors:
Burch, PA
Breen, JK
Buckner, JC
Gastineau, DA
Kaur, JA
Laus, RL
Padley, DJ
Peshwa, MV
Pitot, HC
Richardson, RL
Smits, BJ
Sopapan, P
Strang, G
Valone, FH
Vuk-Pavlovic, S
Citation: Pa. Burch et al., Priming tissue-specific cellular immunity in a phase I trial of autologousdendritic cells for prostate cancer, CLIN CANC R, 6(6), 2000, pp. 2175-2182
Authors:
Small, EJ
Fratesi, P
Reese, DM
Strang, G
Laus, R
Peshwa, MV
Valone, FH
Citation: Ej. Small et al., Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells, J CL ONCOL, 18(23), 2000, pp. 3894-3903